FDA.reportPublic FDA data

blemish care pads with bija seed oil

Manufacturer
Innisfree | Kolmar Korea Co., Ltd.
Effective date
2020-11-20
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 23:06:07

Label at a glance#

Productblemish care pads with bija seed oil
Active ingredientSALICYLIC ACID
Label structure9 sections

Indications and uses

For the treatment of acne. Helps clear up acne blemishes and allows skin to heal Penetrates pores to control acne pimples Helps prevent new acne blemishes, pimples from forming

Dosage and administration

After cleansing, wipe across the dry skin once or twice daily. The tingling sensation and dryness may occur for a moment, but this is normal. Do not use near eye area or burning and stinging will result. clean the skin thoroughly before applying this product cover te entire affected area with a thin layer one to three times daily because excessive drying of the skin may occur, start with one application daily, the...

Storage and handling

Store at room temperature

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid (1%)

PURPOSE

OTC - PURPOSE SECTION

Acne treatment

Uses

INDICATIONS & USAGE SECTION

  • For the treatment of acne.
  • Helps clear up acne blemishes and allows skin to heal
  • Penetrates pores to control acne pimples
  • Helps prevent new acne blemishes, pimples from forming

WARNINGS

WARNINGS SECTION

For external use only.

OTC - WHEN USING SECTION

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

After cleansing, wipe across the dry skin once or twice daily. The tingling sensation and dryness may occur for a moment, but this is normal. Do not use near eye area or burning and stinging will result.

  • clean the skin thoroughly before applying this product
  • cover te entire affected area with a thin layer one to three times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

OTHER INFORMATION

STORAGE AND HANDLING SECTION

Store at room temperature

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

water / aqua / eau, sd alcohol 40-b, propanediol, glycerin,

peg-40 hydrogenated castor oil, c12-14 pareth-12, methylpropanediol, bis-peg-18
methyl ether dimethyl silane, butylene glycol, polyquaternium-51, fragrance /
parfum, pteris multifida extract, avena sativa (oat) kernel extract, hydrogenated
lecithin, cynara scolymus (artichoke) leaf extract, beta-glucan, 1,2-hexanediol,
ulmus davidiana root extract, torreya nucifera seed oil, amaranthus caudatus
seed extract, opuntia coccinellifera fruit extract, camellia sinensis leaf extract,
camellia japonica leaf extract, orchid extract, citrus unshiu peel extract, bht

QUESTIONS?

SPL UNCLASSIFIED SECTION

support@us.amorepacific.com , support@ca.amorepacific.com

PRINCIPAL DISPLAY PANEL - 80 g Jar Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

innisfree

blemish care pads

with bija seed oil

NET WT. 2.82 OZ./80 g (45 pads)

PRINCIPAL DISPLAY PANEL - 80 g Jar Carton
PRINCIPAL DISPLAY PANEL - 80 g Jar Carton

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71220-08171220-081-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 21 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
PROPANEDIOL5965N8W85TIACT
GLYCERINPDC6A3C0OXIACT
POLYOXYL 40 HYDROGENATED CASTOR OIL7YC686GQ8FIACT
C12-14 PARETH-12M0LJS773XWIACT
METHYLPROPANEDIOLN8F53B3R4RIACT
BIS-PEG-18 METHYL ETHER DIMETHYL SILANEOEB4R3WW9CIACT
BUTYLENE GLYCOL3XUS85K0RAIACT
OATZ6J799EAJKIACT
HYDROGENATED SOYBEAN LECITHINH1109Z9J4NIACT
CYNARA SCOLYMUS LEAFB71UA545DEIACT
1,2-HEXANEDIOLTR046Y3K1GIACT
ULMUS DAVIDIANA ROOTURQ79U8261IACT
TORREYA NUCIFERA SEED OIL33JR96IW2BIACT
AMARANTHUS CAUDATUS SEEDFJ722PPQ9MIACT
OPUNTIA COCHENILLIFERA FRUIT838ZTK02KHIACT
GREEN TEA LEAFW2ZU1RY8B0IACT
CAMELLIA JAPONICA LEAF4E3VE6KTLYIACT
TANGERINE PEELJU3D414057IACT
BUTYLATED HYDROXYTOLUENE1P9D0Z171KIACT
SALICYLIC ACIDO414PZ4LPZACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b4900f1a-150a-9a9a-e053-2995a90ae3d67bc00e81-0a9c-7b85-e053-2991aa0a7a512020-11-20WarningsExact identifier
spl id: b4900f1a-150a-9a9a-e053-2995a90ae3d6
spl set id: 7bc00e81-0a9c-7b85-e053-2991aa0a7a51

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.